Related references
Note: Only part of the references are listed.METTL3 is essential for normal progesterone signaling during embryo implantation via m(6)A-mediated translation control of progesterone receptor
Zhan-Hong Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)
RNA N6-methyladenosine modifications and potential targeted therapeutic strategies in kidney disease
Wei-Jian Ni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2023)
Upregulation of C/EBP Homologous Protein induced by ER Stress Mediates Epithelial to Myofibroblast Transformation in ADTKD-UMOD
Dan Wang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2022)
Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms
Jia-Nan Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Molecular subtypes of m6A RNA methylation modification patterns and their clinical significance in clear cell renal cell carcinoma
Bo Guan et al.
TRANSLATIONAL CANCER RESEARCH (2022)
NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2
Decai Wang et al.
CANCERS (2022)
Comprehensive RNA-seq reveals molecular changes in kidney malignancy among people living with HIV
Juan Bao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer
Zhiming Gui et al.
JOURNAL OF ONCOLOGY (2022)
Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer
Xianchao Sun et al.
BIOENGINEERED (2022)
Uromodulin: Roles in Health and Disease
Celine Schaeffer et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 83 (2021)
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia
Eliza Yankova et al.
NATURE (2021)
A comprehensive review of m6A/m6Am RNA methyltransferase structures
Stephanie Oerum et al.
NUCLEIC ACIDS RESEARCH (2021)
EGR2-mediated regulation of m6A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization
Yufan Ying et al.
CELL DEATH & DISEASE (2021)
The role of m6A modification in the biological functions and diseases
Xiulin Jiang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
The epitranscriptome beyond m6A
David Wiener et al.
NATURE REVIEWS GENETICS (2021)
m6A RNA modification modulates gene expression and cancer-related pathways in clear cell renal cell carcinoma
Yimeng Chen et al.
EPIGENOMICS (2020)
Effect of m6A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma
Jiawu Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Chronic Kidney Disease After Partial Nephrectomy in Patients With Preoperative Inconspicuous Renal Function - Curiosity or Relevant Issue?
Malin Nientiedt et al.
CLINICAL GENITOURINARY CANCER (2020)
Epidemiology of Renal Cell Carcinoma
Umberto Capitanio et al.
EUROPEAN UROLOGY (2019)
Autosomal dominant tubulointerstitial kidney disease
Olivier Devuyst et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Functions of N6-methyladenosine and its role in cancer
Liuer He et al.
MOLECULAR CANCER (2019)
dLimited antibody specificity compromises epitranscriptomic analyses
Mark Helm et al.
NATURE COMMUNICATIONS (2019)
Link Between m6A Modification and Cancers
Zhen-Xian Liu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2018)
Translating the epitranscriptome
Thomas Philipp Hoernes et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2017)
Detecting RNA modifications in the epitranscriptome: predict and validate
Mark Helm et al.
NATURE REVIEWS GENETICS (2017)
RNA fate determination through cotranscriptional adenosine methylation and microprocessor binding
Philip Knuckles et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
RNA fate determination through cotranscriptional adenosine methylation and microprocessor binding
Philip Knuckles et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
NDUFA4L2 is associated with clear cell renal cell carcinoma malignancy and is regulated by ELK1
Lei Wang et al.
PEERJ (2017)
Associations of Urinary Uromodulin with Clinical Characteristics and Markers of Tubular Function in the General Population
Menno Pruijm et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma
Denise R. Minton et al.
CLINICAL CANCER RESEARCH (2016)
Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients
Dominik Steubl et al.
MEDICINE (2016)
N6-methyladenosine-encoded epitranscriptomics
Nian Liu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Update: Mechanisms Underlying N6-Methyladenosine Modification of Eukaryotic mRNA
Yang Wang et al.
TRENDS IN GENETICS (2016)
N6-methyladenosine-encoded epitranscriptomics
Nian Liu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing
Oystein S. Eikrem et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2016)
HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events
Claudio R. Alarcon et al.
CELL (2015)
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Xiao Wang et al.
CELL (2015)
Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome
Bastian Linder et al.
NATURE METHODS (2015)
Perturbation of m6A Writers Reveals Two Distinct Classes of mRNA Methylation at Internal and 5′ Sites
Schraga Schwartz et al.
CELL REPORTS (2014)
High-Resolution Mapping Reveals a Conserved, Widespread, Dynamic mRNA Methylation Program in Yeast Meiosis
Schraga Schwartz et al.
CELL (2013)
Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
Kate D. Meyer et al.
CELL (2012)
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dan Dominissini et al.
NATURE (2012)
A transcriptional network in polycystic kidney disease
L Gresh et al.
EMBO JOURNAL (2004)